Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.

Vaccine · 2020 · PMC7526974 · PMID 32888741

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, there was a trend upwards for serotype IV, which showed a trend of increasing from 1% (95%CI: 0–3) pre-2001 (n = 28/1,440 isolates) to 3% (95%CI: 0–7) in 2001–2006 (n = 77/1,340 isolates), to 5% (95%CI: 3–7) in 2007–2012 (n = 197/3,556 isolates), to 7% (95%CI: 5–10) in 2013–2018 (n = 27/359).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.